Imperative Care announced today that it enrolled the first patient in the CLEAR-IT study evaluating its Symphony and Prodigy ...

Imperative Care, Inc., a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the enrollment of the first patient in the CLEAR ...

Please provide your email address to receive an email when new articles are posted on . An FDA-cleared computer-assisted vacuum thrombectomy system was launched. The next-generation system is designed ...

In a "real-world" international study comprising 1,000 patients, nearly half of stroke survivors achieved good to ideal outcomes at three months after the stroke if they had received mechanical clot ...

PORTAGE, Mich., July 29, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its next-generation InThrill Thrombectomy ...

Please provide your email address to receive an email when new articles are posted on . The FDA designated Inari Medical’s recall of its catheter for clot removal in large blood vessels as class I.

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

A major international analysis of 2,313 patients, median age 71, found that giving an IV clot-busting drug before mechanical clot removal modestly increases brain-bleeding risk compared with ...

Inari Medical has updated use instructions for its ClotTriever XL catheter after four injuries and six deaths were reported in association with the device. The ClotTriever XL is used for removing ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...